No abstract available
Keywords:
CML; childhood leukaemia; early response; outcome; tyrosine kinase inhibitors.
Publication types
-
Clinical Trial
-
Letter
-
Multicenter Study
MeSH terms
-
Adolescent
-
Child
-
Child, Preschool
-
Female
-
Humans
-
Imatinib Mesylate / administration & dosage*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / mortality*
-
Male